Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 25, 2025
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
GlobeNewswire
·
March 25, 2025
Company announcement – No. 6 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, March 25, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …
Hapbee - The Future of Wellness Tech - Takes Center Stage With Gary Brecka on ‘The Ultimate Human’ Podcast
GlobeNewswire
·
March 25, 2025
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Imagine optimizing your sleep, focus, and mood—all without ingesting a single substance. That’s the power of Hapbee Technologies Inc. (TSXV: HAPB; OTCQB: HAPBF), the revolutionary leader in …
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
GlobeNewswire
·
March 25, 2025
SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today announced …
Seattle Plastic Surgery Now Offers Deep Plane Facelift
GlobeNewswire
·
March 25, 2025
SEATTLE, March 25, 2025 (GLOBE NEWSWIRE) -- Among the leading plastic surgery clinics in the Northwest, Seattle Plastic Surgery, is now proud to offer a deep plane facelift to its surgical offerings. A deep plane facelift involves lifting the different …
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Further Strengthens Scientific Advisory Board With Appointment of Dr. Dan J. Stein
GlobeNewswire
·
March 25, 2025
TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) ("PBM" or "Psyence Biomed"), has announced that it has expanded …
Leylah Annie & Family Foundation Partners with First Serve Miami to Empower Local Youth Through Tennis
GlobeNewswire
·
March 25, 2025
MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- Tennis star Leylah Fernandez and her family’s nonprofit, the Leylah Annie …
American Kidney Fund Awards Fellowships to Researchers Studying Non-Invasive Kidney Disease Assessments and Transplant-Associated Thrombotic Microangiopathy
GlobeNewswire
·
March 25, 2025
ROCKVILLE, Md., March 25, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce Dr. Momen Abbasi and Dr. Api Chewcharat as the recipients of this year’s Clinical Scientist in Nephrology (CSN) fellowship program. Dr. Abbasi, a …
USAHS Faculty and Occupational Therapist Dr. Sabina Khan Receives the 2025 Vince Hutchins Leadership Award
GlobeNewswire
·
March 25, 2025
MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- The University of St. Augustine for Health Sciences (USAHS) proudly announces that Dr. Sabina Khan is the first occupational therapist to be honored with the 2025 Vince Hutchins Leadership Award by the Association …
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
GlobeNewswire
·
March 25, 2025
At 6 months, the WRAPSODY CIE achieved 89.8% and 72.6% target lesion primary patency and access circuit primary patency, respectively. At 12 months, the WRAPSODY CIE achieved 70.1% and 58.1% target lesion primary patency and access circuit primary patency …
Distalmotion Completes First US Sale of its DEXTER® Robotic Surgery System to Memorial Hermann Health System
GlobeNewswire
·
March 25, 2025
Lausanne, Switzerland, March 25, 2025 (GLOBE NEWSWIRE) -- Distalmotion announces that it completed the first US sale and delivery of the DEXTER Robotic Surgery System to Memorial Hermann Health System in Houston, Texas in early February. This milestone …
Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity
GlobeNewswire
·
March 25, 2025
Helicore’s first-in-human study is designed to evaluate the safety and tolerability of HCR-188 in a single and multiple ascending dose study Top-line safety data anticipated in the second half of 2025 SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE …
LiveWorld Reports 2024 Financial Results
GlobeNewswire
·
March 25, 2025
CAMPBELL, Calif. and NEW YORK , March 25, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for the year 2024. Twelve Months 2024 Financial and Business Highlights Total twelve months revenues of $11.3 million, …
Emerald Isle Health & Recovery Announces New Chief Executive Officer
GlobeNewswire
·
March 25, 2025
SUN CITY, Ariz., March 25, 2025 (GLOBE NEWSWIRE) -- Emerald Isle Health …
Marius Pharmaceuticals Strengthens IP Portfolio with New KYZATREX® (testosterone undecanoate) CIII Capsules Formulation Patent
GlobeNewswire
·
March 25, 2025
RALEIGH, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announced today that the United States Patent and Trademark Office (USPTO) has issued …
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
GlobeNewswire
·
March 25, 2025
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today provided shareholders with a status …
Digital Utilities Ventures Acquires Lifestyle Dock Company, and Expands Market Reach for Easy NanoVoid™ Technology
GlobeNewswire
·
March 25, 2025
Key Highlights: Strategic Acquisition for Market Expansion: Digital Utilities Ventures (OTC: DUTV) acquires Lifestyle Dock Company (LDC), unlocking a potential $3.4 million in additional revenue and expanding the reach of its patented Easy NanoVoid™ water …
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada
GlobeNewswire
·
March 25, 2025
Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss marketplace DALLAS, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company …
PathAI Showcases AI-Powered Pathology Innovations at the United States and Canadian Academy of Pathology (USCAP) 114th Annual Meeting
GlobeNewswire
·
March 25, 2025
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced its participation in the United States and Canadian Academy of Pathology (USCAP) 114th Annual Meeting, taking place March 22–27, 2025, in …
Shineco Announces Acquisition of Medical Device Company
GlobeNewswire
·
March 25, 2025
The Acquisition is Expected to Create Immediate Synergies with the Company’s Existing Medical Device Business BEIJING, March 25, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical …
Oncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and IL-2, Highlights Findings at SWCR 2025 Conference
GlobeNewswire
·
March 25, 2025
AGOURA HILLS, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), ”), a leader in RNA-based therapeutics, announced today the successful completion of a Phase 1 clinical trial …